Low frequency of PIM3 gene in patients with monoclonal gammopathies

Area of Science:

• Biochemistry
• Genetics
• Immunology

Background:

• Monoclonal gammopathies are a group of plasma cell disorders.
• Protease inhibitor (PI) phenotypes are genetically determined and can vary between populations.
• Understanding PI phenotype distribution is crucial for population genetics and disease association studies.

Purpose of the Study:

• To investigate the distribution of protease inhibitor (PI) phenotypes and PI M subtypes in patients with monoclonal gammopathies.
• To compare PI phenotype and gene frequencies between patients and healthy blood donors.
• To identify any significant associations between PI variants and monoclonal gammopathies.

Main Methods:

• Isoelectric focusing in thin-layer polyacrylamide gels (pH 4-5) was used to analyze PI phenotypes.
• The study included 200 patients with monoclonal gammopathies and 320 healthy blood donors.
• Statistical analysis, including the chi-squared test, was employed to compare distributions and gene frequencies.

Main Results:

• Significant differences in PI phenotypes (chi 2 = 16.5, p = 0.02) and gene frequencies (chi 2 = 17.6, p = 0.0014) were observed between patients and controls.
• A lower frequency of the PI M3 variant was found in patients, including homozygous (PI M3) and heterozygous forms (PI M1M3, PI M2M3).
• No significant difference in PIz allele frequencies was detected between the patient group and healthy controls.

Conclusions:

• The distribution of protease inhibitor (PI) phenotypes and gene frequencies differs significantly between individuals with monoclonal gammopathies and healthy individuals.
• The PI M3 variant appears to be less common in patients with monoclonal gammopathies.
• Further research is warranted to elucidate the specific role of PI variants in the pathogenesis or susceptibility to monoclonal gammopathies.